Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Maze Therapeutics, Common Stock

MAZE

NMQ

$12

+$0.68

(6.01%)

Sector: Healthcare

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$525.32M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

286.83K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$10.92 L

$17 H

$12

About Maze Therapeutics, Common Stock

Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in harnessing the power of human genetics and variant functionalization with its Maze Compass platform to develop small-molecule precision medicines for the treatment of renal, cardiovascular and related metabolic diseases, including obesity. The Compass platform has been purpose-built to inform all phases of drug discovery and development process through clinical trial design, advancing two wholly owned lead programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach to chronic kidney disease (CKD). Its lead program, MZE829, is an oral, small-molecule inhibitor of apolipoprotein L1, or APOL1, for the treatment of patients with APOL1 kidney disease, or AKD. Its second lead program, MZE782, is an oral, small-molecule inhibitor of the solute transporter SLC6A19, a novel CKD target. more

Sector: Healthcare

Returns

Data is not properly formatted.

Time Frame	MAZE		S&P500
1-Week Return	-10.31%%	%	1.53%%
1-Month Return	-25%%	%	4.75%%

Financials

	Dec '22	Dec '23
Total Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	111.03M	98.55M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.76,"profit":true}]
Operating Income	(111.03M)	(98.55M)	[{"date":"2022-12-31","value":-11102600000,"profit":false},{"date":"2023-12-31","value":-9855100000,"profit":false}]
Total Non-Operating Income/Expense	(3.91M)	(1.86M)	[{"date":"2022-12-31","value":-391400000,"profit":false},{"date":"2023-12-31","value":-186400000,"profit":false}]
Pre-Tax Income	(114.94M)	(100.42M)	[{"date":"2022-12-31","value":-11494000000,"profit":false},{"date":"2023-12-31","value":-10041500000,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	(114.94M)	(100.42M)	[{"date":"2022-12-31","value":-11494000000,"profit":false},{"date":"2023-12-31","value":-10041500000,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(114.94M)	(100.42M)	[{"date":"2022-12-31","value":-11494000000,"profit":false},{"date":"2023-12-31","value":-10041500000,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

	Dec '22	Dec '23
Total Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	-	(11.24%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Operating Income	-	(11.24%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Total Non-Operating Income/Expense	-	(52.38%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Pre-Tax Income	-	(12.64%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(12.64%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(12.64%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

	Sep '23	Dec '23	Sep '24
Total Revenue	-	-	2.50M	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Cost of Revenue	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Gross Profit	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Gross Margin	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

Operating Expenses	25.23M	23.05M	26.73M	[{"date":"2023-09-30","value":94.38,"profit":true},{"date":"2023-12-31","value":86.24,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Operating Income	(25.23M)	(23.05M)	(24.23M)	[{"date":"2023-09-30","value":-2522800000,"profit":false},{"date":"2023-12-31","value":-2305100000,"profit":false},{"date":"2024-09-30","value":-2422900000,"profit":false}]
Total Non-Operating Income/Expense	-	-	(802.00K)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":-80200000,"profit":false}]
Pre-Tax Income	(24.75M)	(26.58M)	(25.03M)	[{"date":"2023-09-30","value":-2474700000,"profit":false},{"date":"2023-12-31","value":-2657700000,"profit":false},{"date":"2024-09-30","value":-2503100000,"profit":false}]
Income Taxes	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

Income From Continuous Operations	(24.75M)	(26.58M)	(24.75M)	[{"date":"2023-09-30","value":-2474700000,"profit":false},{"date":"2023-12-31","value":-2657700000,"profit":false},{"date":"2024-09-30","value":-2475200000,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Net Income	(24.75M)	(26.58M)	(24.75M)	[{"date":"2023-09-30","value":-2474700000,"profit":false},{"date":"2023-12-31","value":-2657700000,"profit":false},{"date":"2024-09-30","value":-2475200000,"profit":false}]

EPS (Diluted)	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

	Sep '23	Dec '23	Sep '24
Total Revenue	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Cost of Revenue	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Gross Profit	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Gross Margin	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

Operating Expenses	-	(8.63%)	15.96%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":-54.08,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]
Operating Income	-	(8.63%)	5.11%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":-168.86,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Pre-Tax Income	-	7.39%	(5.82%)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-09-30","value":-78.66,"profit":false}]
Income Taxes	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	7.39%	(6.87%)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-09-30","value":-92.86,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Net Income	-	7.39%	(6.87%)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-09-30","value":-92.86,"profit":false}]

EPS (Diluted)	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

	Dec '22	Dec '23
Total Assets
Current Assets	106.15M	34.11M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":32.13,"profit":true}]
Non-current Assets	43.81M	37.39M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.36,"profit":true}]
Total Assets	149.96M	71.50M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":47.68,"profit":true}]

Total Liabilities
Current Liabilities	20.78M	16.32M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":78.51,"profit":true}]
Non-current Liabilities	411.63M	429.04M	[{"date":"2022-12-31","value":95.94,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	432.42M	445.35M	[{"date":"2022-12-31","value":97.1,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	(295.27M)	(395.69M)	[{"date":"2022-12-31","value":-29527100000,"profit":false},{"date":"2023-12-31","value":-39568600000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	(282.46M)	(373.85M)	[{"date":"2022-12-31","value":-28245900000,"profit":false},{"date":"2023-12-31","value":-37384800000,"profit":false}]

Total Liabilities & Shareholders Equity	149.96M	71.50M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":47.68,"profit":true}]

	Dec '22	Dec '23
Total Assets
Current Assets	-	(67.87%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Non-current Assets	-	(14.64%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Total Assets	-	(52.32%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	(21.49%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Non-current Liabilities	-	4.23%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	2.99%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	34.01%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	32.35%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(52.32%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

	Dec '23	Jun '24	Sep '24
Total Assets
Current Assets	34.11M	179.40M	153.96M	[{"date":"2023-12-31","value":19.01,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":85.82,"profit":true}]
Non-current Assets	37.39M	36.40M	38.52M	[{"date":"2023-12-31","value":97.07,"profit":true},{"date":"2024-06-30","value":94.47,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Total Assets	71.50M	215.79M	192.48M	[{"date":"2023-12-31","value":33.14,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":89.2,"profit":true}]

Total Liabilities
Current Liabilities	16.32M	21.61M	17.55M	[{"date":"2023-12-31","value":75.52,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":81.25,"profit":true}]
Non-current Liabilities	429.04M	456.56M	459.46M	[{"date":"2023-12-31","value":93.38,"profit":true},{"date":"2024-06-30","value":99.37,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Total Liabilities	445.35M	478.17M	477.01M	[{"date":"2023-12-31","value":93.14,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":99.76,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Retained Earnings	(395.69M)	(289.12M)	(313.88M)	[{"date":"2023-12-31","value":-39568600000,"profit":false},{"date":"2024-06-30","value":-28912400000,"profit":false},{"date":"2024-09-30","value":-31387600000,"profit":false}]
Other Stockholders' Equity	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Total Shareholders' equity	(373.85M)	(262.37M)	(284.53M)	[{"date":"2023-12-31","value":-37384800000,"profit":false},{"date":"2024-06-30","value":-26237300000,"profit":false},{"date":"2024-09-30","value":-28453200000,"profit":false}]

Total Liabilities & Shareholders Equity	71.50M	215.79M	192.48M	[{"date":"2023-12-31","value":33.14,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":89.2,"profit":true}]

	Dec '23	Jun '24	Sep '24
Total Assets
Current Assets	-	425.94%	(14.18%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":-3.33,"profit":false}]
Non-current Assets	-	(2.67%)	5.85%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":-45.67,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]
Total Assets	-	201.79%	(10.80%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":-5.35,"profit":false}]

Total Liabilities
Current Liabilities	-	32.42%	(18.75%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":-57.83,"profit":false}]
Non-current Liabilities	-	6.42%	0.63%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":9.88,"profit":true}]
Total Liabilities	-	7.37%	(0.24%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":-3.28,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Retained Earnings	-	(26.93%)	8.56%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":-314.58,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Total Shareholders' equity	-	(29.82%)	8.45%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":-353.06,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	201.79%	(10.80%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-09-30","value":-5.35,"profit":false}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	(99.20M)	(86.83M)	[{"date":"2022-12-31","value":-9920300000,"profit":false},{"date":"2023-12-31","value":-8682700000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	1.73M	16.39M	[{"date":"2022-12-31","value":10.55,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	(100.64M)	(70.88M)	[{"date":"2022-12-31","value":-10064500000,"profit":false},{"date":"2023-12-31","value":-7088300000,"profit":false}]

Free Cash Flow
Free Cash Flow	(101.17M)	(87.27M)	[{"date":"2022-12-31","value":-10116900000,"profit":false},{"date":"2023-12-31","value":-8726800000,"profit":false}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	-	(12.48%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	848.21%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	-	(29.57%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(13.74%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

	Sep '23	Dec '23	Sep '24
Operating Activities
Net Operating Cash Flow	(19.97M)	(20.64M)	(23.20M)	[{"date":"2023-09-30","value":-1997200000,"profit":false},{"date":"2023-12-31","value":-2064300000,"profit":false},{"date":"2024-09-30","value":-2320500000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	8.00K	16.19M	(2.15M)	[{"date":"2023-09-30","value":0.05,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-09-30","value":-13.28,"profit":false}]

Net Change in Cash	(19.96M)	(4.49M)	(25.46M)	[{"date":"2023-09-30","value":-1996100000,"profit":false},{"date":"2023-12-31","value":-448900000,"profit":false},{"date":"2024-09-30","value":-2545800000,"profit":false}]

Free Cash Flow
Free Cash Flow	(19.97M)	(20.68M)	(23.31M)	[{"date":"2023-09-30","value":-1997200000,"profit":false},{"date":"2023-12-31","value":-2067700000,"profit":false},{"date":"2024-09-30","value":-2330800000,"profit":false}]

	Sep '23	Dec '23	Sep '24
Operating Activities
Net Operating Cash Flow	-	3.36%	12.41%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":27.07,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	202250.00%	(113.28%)	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-09-30","value":-0.06,"profit":false}]

Net Change in Cash	-	(77.51%)	467.12%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":-16.59,"profit":false},{"date":"2024-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	3.53%	12.72%	[{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":27.74,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	MAZE
Current Ratio	8.77

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	MAZE
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	MAZE
Debt Ratio Lower is generally better. Negative is bad.	2.48
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-1.48

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	MAZE
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Maze Therapeutics share price today?

Maze Therapeutics (MAZE) share price today is $12

Can Indians buy Maze Therapeutics shares?

Yes, Indians can buy shares of Maze Therapeutics (MAZE) on Vested. To buy Maze Therapeutics from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MAZE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Maze Therapeutics be purchased?

Yes, you can purchase fractional shares of Maze Therapeutics (MAZE) via the Vested app. You can start investing in Maze Therapeutics (MAZE) with a minimum investment of $1.

How to invest in Maze Therapeutics shares from India?

You can invest in shares of Maze Therapeutics (MAZE) via Vested in three simple steps:

Click on Sign Up or Invest in MAZE stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Maze Therapeutics shares

What is Maze Therapeutics 52-week high and low stock price?

The 52-week high price of Maze Therapeutics (MAZE) is $17. The 52-week low price of Maze Therapeutics (MAZE) is $10.92.

What is Maze Therapeutics price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Maze Therapeutics (MAZE) is 0.00

What is the Market Cap of Maze Therapeutics?

The market capitalization of Maze Therapeutics (MAZE) is $525.32M

What is Maze Therapeutics’s stock symbol?

The stock symbol (or ticker) of Maze Therapeutics is MAZE